GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Omnimmune Holdings Inc (GREY:OMMH) » Definitions » Research & Development

Omnimmune Holdings (Omnimmune Holdings) Research & Development : $0.00 Mil (TTM As of Sep. 2010)


View and export this data going back to 2007. Start your Free Trial

What is Omnimmune Holdings Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Omnimmune Holdings's Research & Development for the three months ended in Sep. 2010 was $0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Sep. 2010 was $0.00 Mil.


Omnimmune Holdings Research & Development Historical Data

The historical data trend for Omnimmune Holdings's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Omnimmune Holdings Research & Development Chart

Omnimmune Holdings Annual Data
Trend May07 May08 Dec09
Research & Development
- - -

Omnimmune Holdings Quarterly Data
May07 Aug07 Nov07 Feb08 May08 Aug08 Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Omnimmune Holdings Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Sep. 2010 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Omnimmune Holdings  (GREY:OMMH) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Omnimmune Holdings Research & Development Related Terms

Thank you for viewing the detailed overview of Omnimmune Holdings's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.


Omnimmune Holdings (Omnimmune Holdings) Business Description

Traded in Other Exchanges
N/A
Address
4600 Post Oak Place, Suite 352, Houston, TX, USA, 77027
Website
Omnimmune Holdings Inc is a development-stage biotechnology company, which is engaged in integrating complementary cancer therapeutic, diagnostic and prognostic technologies.

Omnimmune Holdings (Omnimmune Holdings) Headlines

No Headlines